Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-12,500
Closed -$1.7M – 2187
2025
Q2
$1.7M Sell
12,500
-91,200
-88% -$12M ﹤0.01% 1466
2025
Q1
$13.8M Sell
103,700
-10,100
-9% -$1.29M 0.03% 595
2024
Q4
$12.9M Buy
113,800
+46,400
+69% +$5.36M 0.03% 630
2024
Q3
$7.68M Buy
67,400
+23,200
+52% +$2.54M 0.02% 855
2024
Q2
$4.59M Buy
44,200
+6,000
+16% +$636K 0.01% 1035
2024
Q1
$4.34M Sell
38,200
-300
-0.8% -$34.4K 0.01% 1046
2023
Q4
$4.24M Buy
+38,500
New +$3.85M 0.01% 1011
2021
Q3
– Sell
-200
Closed -$23K – 1874
2021
Q2
$23K Buy
+200
New +$23.3K ﹤0.01% 1912

Other funds holding ABT

Man Group's ABT Position: Q3 2026 in Review

Man Group reduced its Abbott (ABT) stake by 18% in Q3 2026, selling an estimated $15.3M and leaving 654,002 shares worth $64.6M. The position accounts for 0.1% of the portfolio, ranked #236.

Man Group first reported a position in ABT in Q1 2018 and has held it in 32 quarters since. The position peaked at $126M in Q1 2022. 3,043 funds tracked by Wall St. Rank hold ABT as of Q3 2026.

  • Man Group held 654,002 shares of Abbott worth $64.6M as of Q3 2026.
  • Man Group sold 146,717 Abbott shares in Q3 2026, an estimated $15.3M.
  • Abbott made up 0.1% of Man Group's portfolio in Q3 2026, its #236 holding.
  • Man Group first reported a position in Abbott in Q1 2018 and has held it in 32 quarters since.
  • Man Group's Abbott position peaked at $126M in Q1 2022.
  • 3,043 funds tracked by Wall St. Rank held Abbott as of Q3 2026.

Based on Man Group's 13F filing for Q3 2026, filed 16 Nov 2026.